Compare

CJC-1295 (no DAC) vs Ipamorelin

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

CJC-1295 (no DAC)

81 community reports

Positive 2% · Neutral 98% · Negative 0%

Most reported benefits

Sleep
203

Most reported side effects

Headache
198

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
12
100–200
64
200–400
117
400–600
5
600–1000
0
1000–2000
5
2000+
0

How repeat users are trending

Among repeat reporters, 88% said they felt similar to their last entry, 13% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 68 days · Based on 32 repeat reporters

Ipamorelin

102 community reports

Positive 98% · Neutral 2% · Negative 0%

Most reported benefits

Energy
236
Sleep
236

Most reported side effects

Water retention
2
Headache
2

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
12
100–200
63
200–400
137
400–600
22
600–1000
0
1000–2000
0
2000+
2

How repeat users are trending

Among repeat reporters, 98% said they felt similar to their last entry, 2% more positive, and 0% more negative.

Overall, repeat reporters leaned similar or mixed compared to their previous entry.

Median gap between entries: 51 days · Based on 44 repeat reporters